Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone ...
In this video, Rebecca Stone, MD, MS, discussed the need for improved prevention and screening methods for ovarian cancer.
A new study published in the Journal of the American Medical Association revealed that the chance of developing serous ovarian cancer was shown to be reduced by almost 80% when ...
Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator ...
The Oxford-based biotechnology company Theolytics has been awarded €8 million in non-dilutive grant funding from Horizon ...
Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...
Pending final negotiation, grant will fund up to 20 patients in the OCTOPOD-IV Phase 2a expansion study of THEO-260 in platinum-resistant ovarian cancerCompetitive funding award highlights Theolytics’ ...
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Global Ovarian Cancer Research Consortium awarded its inaugural AI Accelerator Grant to an international research team studying whether artificial ...
CNW/ - The Global Ovarian Cancer Research Consortium, of which Ovarian Cancer Canada is a founding member, has awarded its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results